Imatinib, sold under the brand names Gleevec and Glivec (both marketed worldwide by Novartis) among others, is an oral targeted therapy medication used to treat cancer. [2]

Nov 1, 2025 · Imatinib is used alone or together with other medicines to treat different types of cancer or bone marrow conditions. It prevents or stops the growth of cancer cells and is called an …

Dec 11, 2024 · Imatinib (brand names Gleevec [oral tablet], Imkeldi [oral solution]) is used to treat certain types of leukemia (blood cancer), bone marrow disorders, and skin cancer. Imatinib is also …

What is this medication? IMATINIB (i MAT in ib) treats some types of cancer. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer …

Feb 13, 2025 · Find patient medical information for Imatinib (Gleevec, Imkeldi) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings

Imatinib, an oral targeted therapy, inhibits tyrosine kinases specifically BCR-ABL, c-KIT, and PDGFRA. Apart from its remarkable success in CML and GIST, Imatinib benefits various other tumors caused …

Imatinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein in cancer cells. This helps slow or stop the spread of cancer cells. How should this …

What Is Imatinib and How Does It Work?

This page contains brief information about imatinib mesylate and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

Imatinib is a cancer drug. It is used to treat some types of leukaemia, some blood disorders and a rare type of sarcoma called gastro-intestinal stromal tumour (GIST).